{
  "pmid": "23969513",
  "uid": "23969513",
  "title": "Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel.",
  "abstract": "Pertuzumab is a novel antihuman epidermal growth factor receptor 2 (HER2) humanized monoclonal antibody. Combined with trastuzumab plus docetaxel, pertuzumab improved progression-free and overall survival versus trastuzumab plus docetaxel in the phase III CLEOPATRA trial (NCT00567190) in first-line HER2-positive metastatic breast cancer. Thirty-seven patients participated in a pharmacokinetic (PK)/corrected QT interval substudy of CLEOPATRA, which evaluated potential PK drug-drug interaction (DDI). PK parameters were calculated using noncompartmental methods, and DDI analyses were carried out. In the presence of trastuzumab and docetaxel, the mean pertuzumab Cmin and Cmax in cycle 3 were 63.6 and 183 µg/ml, respectively. The pertuzumab concentrations observed were consistent with simulations from a validated population PK model, indicating that trastuzumab and docetaxel did not alter pertuzumab PK. Comparison of geometric least-squares mean PK parameters between arms showed no impact of pertuzumab on the PK of trastuzumab or docetaxel. In conclusion, no PK DDI was observed when pertuzumab, trastuzumab, and docetaxel were combined for the treatment of HER2-positive metastatic breast cancer.",
  "authors": [
    {
      "last_name": "Cortés",
      "fore_name": "Javier",
      "initials": "J",
      "name": "Javier Cortés",
      "affiliations": [
        "aVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain bMedStar Washington Hospital Center, Washington Cancer Institute, Washington, District of Columbia cMid Ohio Oncology/Hematology Inc., The Mark H. Zangmeister Center, Columbus, Ohio dGenentech, South San Francisco, California eMemorial Sloan-Kettering Cancer Center, New York, New York, USA fRiga East University Hospital Oncology Center, Riga, Latvia gDaugavpils Re&gacute;ionālā Slimnīca, Daugavpils, Latvia hGesundheitszentrum Fricktal, Spital Rheinfelden & Laufenburg, Rheinfelden, Switzerland iNational Hospital Organization Osaka National Hospital, Osaka-City, Osaka, Japan jRoche Products Limited, Welwyn Garden City, UK kPharsight, Montreal, Quebec, Canada."
      ]
    },
    {
      "last_name": "Swain",
      "fore_name": "Sandra M",
      "initials": "SM",
      "name": "Sandra M Swain",
      "affiliations": []
    },
    {
      "last_name": "Kudaba",
      "fore_name": "Iveta",
      "initials": "I",
      "name": "Iveta Kudaba",
      "affiliations": []
    },
    {
      "last_name": "Hauschild",
      "fore_name": "Maik",
      "initials": "M",
      "name": "Maik Hauschild",
      "affiliations": []
    },
    {
      "last_name": "Patel",
      "fore_name": "Taral",
      "initials": "T",
      "name": "Taral Patel",
      "affiliations": []
    },
    {
      "last_name": "Grincuka",
      "fore_name": "Elza",
      "initials": "E",
      "name": "Elza Grincuka",
      "affiliations": []
    },
    {
      "last_name": "Masuda",
      "fore_name": "Norikazu",
      "initials": "N",
      "name": "Norikazu Masuda",
      "affiliations": []
    },
    {
      "last_name": "McNally",
      "fore_name": "Virginia",
      "initials": "V",
      "name": "Virginia McNally",
      "affiliations": []
    },
    {
      "last_name": "Ross",
      "fore_name": "Graham",
      "initials": "G",
      "name": "Graham Ross",
      "affiliations": []
    },
    {
      "last_name": "Brewster",
      "fore_name": "Mike",
      "initials": "M",
      "name": "Mike Brewster",
      "affiliations": []
    },
    {
      "last_name": "Marier",
      "fore_name": "Jean-François",
      "initials": "JF",
      "name": "Jean-François Marier",
      "affiliations": []
    },
    {
      "last_name": "Trinh",
      "fore_name": "My My",
      "initials": "MM",
      "name": "My My Trinh",
      "affiliations": []
    },
    {
      "last_name": "Garg",
      "fore_name": "Amit",
      "initials": "A",
      "name": "Amit Garg",
      "affiliations": []
    },
    {
      "last_name": "Nijem",
      "fore_name": "Ihsan",
      "initials": "I",
      "name": "Ihsan Nijem",
      "affiliations": []
    },
    {
      "last_name": "Visich",
      "fore_name": "Jennifer",
      "initials": "J",
      "name": "Jennifer Visich",
      "affiliations": []
    },
    {
      "last_name": "Lum",
      "fore_name": "Bert L",
      "initials": "BL",
      "name": "Bert L Lum",
      "affiliations": []
    },
    {
      "last_name": "Baselga",
      "fore_name": "José",
      "initials": "J",
      "name": "José Baselga",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Anti-cancer drugs",
    "iso_abbreviation": "Anticancer Drugs",
    "issn": "1473-5741",
    "issn_type": "Electronic",
    "volume": "24",
    "issue": "10",
    "pub_year": "2013",
    "pub_month": "Nov"
  },
  "start_page": "1084",
  "end_page": "1092",
  "pages": "1084-92",
  "language": "eng",
  "publication_types": [
    "Clinical Trial, Phase III",
    "Journal Article",
    "Randomized Controlled Trial",
    "Research Support, Non-U.S. Gov't"
  ],
  "keywords": [
    "Antibodies, Monoclonal, Humanized",
    "Antineoplastic Combined Chemotherapy Protocols",
    "Breast Neoplasms",
    "Docetaxel",
    "Drug Administration Schedule",
    "Drug Interactions",
    "Female",
    "Humans",
    "Middle Aged",
    "Models, Biological",
    "Neoplasm Metastasis",
    "Receptor, ErbB-2",
    "Taxoids",
    "Trastuzumab"
  ],
  "article_ids": {
    "pubmed": "23969513",
    "doi": "10.1097/CAD.0000000000000016"
  },
  "doi": "10.1097/CAD.0000000000000016",
  "dates": {
    "completed": "2014-05-05",
    "revised": "2018-12-02"
  },
  "chemicals": [
    "Antibodies, Monoclonal, Humanized",
    "Taxoids",
    "Docetaxel",
    "ERBB2 protein, human",
    "Receptor, ErbB-2",
    "pertuzumab",
    "Trastuzumab"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:22:09.142524",
    "pmid": "23969513"
  }
}